C L I N I C A L chem istry RE AG ENTS
www.sekisuidiagnostics.com
CO2
measurements
are used as
an aid in the
diagnosis and
treatment of
an acid-base
imbalance.
METHOD: ENZYMATIC (PHOSPHOENOLPYRUVATE CARBOXYLASE); RATE
features:
FOR THE QUANTITATIVE MEASUREMENT OF CARBON DIOXIDE
4 One part stable liquid
Carbon Dioxide
(CO2) L3K®
4 Wide linear range
4 Negligible bilirubin and
hemoglobin interferences
4 Excellent precision
Sekisui’s Carbon Dioxide (CO2) L3K® Reagent uses
an enzymatic procedure which is easy to use and
applicable to routine laboratory instrumentation.
It is intended for the measurement of carbon
dioxide in serum and plasma.
o rdering inf o r m at i o n benefits:
4 Easy to use, no additional
preparation required
4 Reduces the need for diluting
and repeat testing
4 Dependable results
C on f i g u r at ion cata log n u m ber
C A R B O N D I O X I DE ( C o2 ) L 3 K ® R1 5 X 100 mL 299-17
(ROCHE/HITACHI ® COMPATIBLE WEDGE)
C A R B O N D I O X I DE ( C o2 ) L 3 K ® R1 6 X 30 mL 299-30
C A RB O N D I O X I DE ( Co 2 ) L 3 K ®
R1 4 X 500 mL 299-50
C A RB O N D I O X I DE ( Co 2 ) L 3 K ® R1 1 X 500 mL 299-55
C A RB O N D I O X I DE ( Co 2 ) L 3 K ®
R1 1 X 1000 mL 299-80
D C - C A L C A L I BRATO R
5 X 3 mL SE-035
D C - TRO L LE V EL 1 10 X 5 mL SM -052
D C - TRO L LE V EL 2
10 X 5 mL SM-056
C 0 2 STA N D AR D *
1 X 15 mL DIAGNOSTI C S
The Americas
international
Sekisui Diagnostics, LLC
4 Hartwell Place
Lexington, MA 02421
Phone: 800 332 1042
Fax: 800 762 6311
Email: [email protected]
Sekisui Diagnostics (UK) Limited
50 Gibson Drive
Kings Hill, West Malling, Kent, ME19 4AF, UK
Phone: +44 (0) 1732 220022
Fax: +44 (0) 1732 220024
Email: [email protected]
©2013 Sekisui Diagnostics, LLC – All rights reserved.
9217
*Not available in Canada and Europe
80-7441-00-02 03/13
C L I N I C A L chem istry RE AG ENTS Carbon Dioxide L3K®
www.sekisuidiagnostics.com
Perf orman ce C h a r ac t e r i s t ics Pre cis ion
Within-Run: <1.7%
Total Precision: <1.7%
A ccurac y SERU M
Slope: 1.00
Intercept: -0.42 mmol/L (-0.42 mEq/L)
Correlation Coefficient: 0.9861
performance of this method (y) with serum samples was compared
The
PLASMA
with the performance of a similar carbon dioxide method (x) on a
Slope:
0.950
Cobas Mira analyzer.
The performance of this method (y) with plasma samples (y) was compared
Intercept: 1.35 mmol/L (1.35 mEq/L)
to this method with serum samples (x) on an Advia® 1650 analyzer.
Correlation Coefficient: 0.9636
®
Lin e a r it y 2.9 to 50.0 mmol/L (2.9-50.0 mEq/L)
No s ignificant int e r f e r ence s
up to l e ve ls indicat ed
Hemoglobin: 600 mg/dL (93 μmol/L)
Bilirubin: 40 mg/dL (684 μmol/L)
Intralipid: 1000 mg/dL (3000 mg/dL
[34 mmol/L] Simulated Triglycerides)
R ef e r enc e range (1) 22 - 29 mmol/L (22 - 29 mEq/L)
(1) Tietz, N.W. (Editor), Textbook of Clinical Chemistry, W.B. Saunders Co., Philadelphia (1986).
NOTES:
DIAGNOSTI C S
The Americas
international
Sekisui Diagnostics, LLC
4 Hartwell Place
Lexington, MA 02421
Phone: 800 332 1042
Fax: 800 762 6311
Email: [email protected]
Sekisui Diagnostics (UK) Limited
50 Gibson Drive
Kings Hill, West Malling, Kent, ME19 4AF, UK
Phone: +44 (0) 1732 220022
Fax: +44 (0) 1732 220024
Email: [email protected]
©2013 Sekisui Diagnostics, LLC – All rights reserved.